34375500|PMC8447445
{'Chemical', 'Disease', 'Species', 'Gene'}
There is a bidirectional relationship between coronavirus disease 2019 (COVID-19) and diabetes. The association between bodyweight reduction and improvement in glycemic control reiterated the importance of maintaining a healthy lifestyle during the COVID-19 pandemic. Available evidence so far suggested that metformin might be associated with reduced mortality, and the risks and benefits of using metformin had been determined in a multicenter retrospective analysis of 1,213 COVID-19 patients with pre-existing type 2 diabetes in China.